Bugworks

Drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR).

Launch date

Feb 2014

Employees

Market cap

Enterprise valuation

Bengaluru Karnataka (HQ)

Date	Investors	Amount	Round
-	CARB-X	N/A	-
Nov 2015	N/A	$1.6m	Early VC
Jul 2017	N/A	N/A	Early VC
Aug 2018	3one4 Capital UTEC - The University of Tokyo Edge Capital Partners	$9.0m	Series A
Apr 2020*	Global Brain Corporation UTEC - The University of Tokyo Edge Capital Partners	$7.5m	Series B
Feb 2022*	Global Brain Corporation 3one4 Capital Lightrock The University of Tokyo Acquipharma Holdings IM Holdings BV	$18.0m	Series B
Mar 2024*	N/A	$6.8m	Growth Equity VC
Total Funding		CAD58.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Bugworks